What is the intrinsic value of VIH1.DE?
As of 2025-07-11, the Intrinsic Value of VIB Vermoegen AG (VIH1.DE) is
21.57 EUR. This VIH1.DE valuation is based on the model Peter Lynch Fair Value.
With the current market price of 7.30 EUR, the upside of VIB Vermoegen AG is
195.45%.
Is VIH1.DE undervalued or overvalued?
Based on its market price of 7.30 EUR and our intrinsic valuation, VIB Vermoegen AG (VIH1.DE) is undervalued by 195.45%.
21.57 EUR
Intrinsic Value
VIH1.DE Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
(639.70) - (48.99) |
(72.93) |
-1099.0% |
| DCF (Growth 10y) |
(52.10) - (716.36) |
(79.02) |
-1182.4% |
| DCF (EBITDA 5y) |
(46.84) - (53.67) |
(1,234.50) |
-123450.0% |
| DCF (EBITDA 10y) |
(50.13) - (64.49) |
(1,234.50) |
-123450.0% |
| Fair Value |
21.57 - 21.57 |
21.57 |
195.45% |
| P/E |
6.60 - 17.87 |
11.93 |
63.4% |
| EV/EBITDA |
17.17 - 23.00 |
20.90 |
186.2% |
| EPV |
14.21 - 66.44 |
40.32 |
452.4% |
| DDM - Stable |
19.35 - 78.68 |
49.01 |
571.4% |
| DDM - Multi |
14.18 - 47.18 |
22.09 |
202.7% |
VIH1.DE Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
241.26 |
| Beta |
0.60 |
| Outstanding shares (mil) |
33.05 |
| Enterprise Value (mil) |
985.56 |
| Market risk premium |
5.10% |
| Cost of Equity |
5.82% |
| Cost of Debt |
7.65% |
| WACC |
6.29% |